TETERBORO, N.J., February 20, 1998 –James D. Chambers has been
appointed Senior Vice President, Marketing and Business Development, at Quest Diagnostics
Incorporated (NYSE: DGX), reporting to Kenneth W. Freeman, Chairman and Chief Executive
Officer.
In this role, Mr. Chambers will be responsible for growth markets, with an emphasis on
large buyers of health care services, including hospital networks, managed care companies
and group purchasing organizations. In addition, he will oversee marketing, with
particular emphasis on identifying and pursuing emerging growth opportunities. He succeeds
Don M. Hardison Jr., who will be leaving the company to pursue other interests.
"Jim's breadth of experience, energy and strong leadership will provide the
spark needed to successfully implement our business strategy to become the preferred
partner with large buyers," said Mr. Freeman.
Mr. Chambers, 41, previously served as Vice President, Administration, with
responsibility for Investor Relations and Communications. Kenneth R. Finnegan, Vice
President, Treasurer, will assume additional responsibility for Investor Relations. Kurt
R. Fischer, Vice President, Human Resources, will assume additional responsibility for
overseeing Corporate Communications.
Mr. Chambers joined the company in 1993 as Treasurer, and has also served as Chief
Financial Officer and Vice President, Billing and Investor Relations. Since 1986, he
served in a variety of executive positions at Corning Incorporated, from which Quest
Diagnostics was spun off at the end of 1996. He graduated from Dickinson College with a
B.A. in 1978, received his MBA from Southern Methodist University in 1980, and a
Master's Degree in International Management from the American Graduate School of
International Management in 1980.
Quest Diagnostics Incorporated is one of the nation's leading providers of
diagnostic testing, information and services with laboratories across the United States.
The wide variety of tests performed on human tissue and fluids helps doctors and hospitals
diagnose, treat and monitor disease. Its Nichols Institute unit conducts research,
specializes in esoteric testing using genetic screening and other advanced technologies,
performs clinical studies testing, and manufactures and distributes diagnostic test kits
and instruments. Quest Informatics collects and analyzes laboratory, pharmaceutical and
other data to help large healthcare customers identify and monitor patients who are
at-risk for certain diseases and to use clinical data for other related business
activities. Additional company information can be found on the Internet at:
www.questdiagnostics.com.